Grant History
Every grant Angiosarcoma Awareness has awarded since 2012, all focused on angiosarcoma research and the patients it affects.
$717K+
total funded
21
grants awarded
2012–2026
years of funding
$100,000
largest single grant (2019)
Where the money has gone
Most funding goes directly to research, with a share set aside to help patients reach expert care and clinical trials.
Research projects · $662,200
18 grants for lab research, cell and animal models, genomics and research fellowships
Patient support · $55,000
3 grants for clinical trial travel, patient advocacy and access to second opinions
All grants
Newest first. Each grant shows its year, award type, project, recipient and amount.
Year
Type of award
Recipient
Research institution
Project title
Amount
Year
2026
Type of award
Research fellowship
Recipient
Tempus AI, Inc.
Project title
The fellow will analyze angiosarcoma molecular, pathology, and clinical data to identify potential therapeutic targets and biomarkers, study circulating tumor DNA, and relate molecular findings to patient outcomes.
Amount
$65,000
Year
2025
Type of award
Research grant
Recipient
Dr. Brian Van Tine
Research institution
Washington University
Project title
Studying the surface protein expression on angiosarcoma
Amount
$50,000
Year
2024
Type of award
Patient travel
Recipient
Dr. Edmund Bartlett
Research institution
Memorial Sloan Kettering Cancer Center
Project title
Patient travel support for NCT05755113
Amount
$20,000
Year
2024
Type of award
General grant
Recipient
Harmony Knutson
Research institution
Alliance for Rare Cancer (Jed Taxel)
Project title
Start up funds (enabled a 1 million dollar grant from Chan Zuckerberg including angiosarcoma)
Amount
$10,000
Year
2023
Type of award
Research grant
Recipient
Dr. Moony Tseng
Research institution
Broad Institute of MIT and Harvard
Project title
Development of angiosarcoma cell line models
Amount
$35,000
Year
2023
Type of award
Research grant
Recipient
Dr. Elinor Karlsson
Research institution
Darwin's Ark Foundation
Project title
Monitoring onset of hemangiosarcoma from environmental exposure to vinyl chloride in dogs
Amount
$10,000
Year
2023
Type of award
Patient travel
Recipient
Dr. Ciara Kelly
Research institution
Memorial Sloan Kettering Cancer Center
Project title
Patient travel support for NCT05755113
Amount
$5,000
Year
2022
Type of award
Research grant
Recipient
Moony Tseng
Research institution
Broad Institute's Cancer Cell Line Factory
Project title
Angiosarcoma Living Tissue Donation Initiative II.
Amount
$35,000
Year
2021
Type of award
Research grant
Recipient
—
Research institution
Broad Institute's Cancer Cell Line Factory
Project title
To collect living tissue samples.
Amount
$25,000
Year
2020
Type of award
Research grant
Recipient
Vinod Ravi, MD
Research institution
The University of Texas M.D. Anderson Cancer Center, Houston, TX
Project title
Development of patient-derived Angiosarcoma cell line model to investigate synthetic lethality.
Amount
$12,000
Year
2019
Type of award
Patient advocacy
Recipient
—
Research institution
Sarcoma Alliance
Project title
Patient advocacy and access to second opinions.
Amount
$30,000
Year
2019
Type of award
Research grant
Recipient
Nikhil Wagle, MD
Research institution
Broad Institute of MIT and Harvard
Project title
Germline Analysis for Pathogenic Variants in Angiosarcoma
Amount
$100,000
Year
2018
Type of award
General grant
Recipient
Greg Cote, MD
Research institution
Massachusetts General Hospital
Project title
—
Amount
$25,000
Year
2016
Type of award
Research grant
Recipient
Jun-lin Guan, Ph.D.
Research institution
University of Cincinnati College of Medicine
Project title
Therapeutic targeting of mTORC1 for lymphangiosarcoma using a novel mouse model.
Amount
$43,200
Year
2015
Type of award
Research grant
Recipient
Greg Cote, MD
Research institution
Massachusetts General Hospital
Project title
Development of an angiosarcoma patient-derived xenograft mouse model.
Amount
$50,000
Year
2014
Type of award
Research grant
Recipient
Brian Van Tine, MD, Ph.D.
Research institution
Washington University School of Medicine, St. Louis MO
Project title
Establishing an integrative Omics Approach to Identify Therapeutic Targets in Angiosarcoma.
Amount
$27,000
Year
2014
Type of award
Research grant
Recipient
Nancy Demore, MD
Research institution
Medical University of South Carolina
Project title
Generation of a Pegylated SFRP2 Fragmented Antibody for the treatment of Angiosarcoma.
Amount
$25,000
Year
2013
Type of award
Research grant
Recipient
Vinod Ravi, MD
Research institution
The University of Texas MD Anderson Cancer Center, Houston, TX
Project title
Identification of therapeutic targets in angiosarcoma using genomic and proteomic analysis and in vivo evaluation of the efficacy of inhibitors to identified tumor explants.
Amount
$25,000
Year
2013
Type of award
Research grant
Recipient
Soner Altiok, MD, Ph.D.
Research institution
H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL.
Project title
Assessment of the Therapeutic Efficacy of Wee1 Inhibition in Patient Derived Xenograft Mouse Models of Human Angiosarcoma.
Amount
$25,000
Year
2013
Type of award
Partnership
Recipient
Cristina Antonescu, MD
Research institution
Memorial Sloan Kettering Cancer Center, with Cycle for Survival
Project title
Upregulation of angiogenic regulators in angiosarcoma using genomic approaches to investigate dysregulation in miRNAs and whole genome methylation
Amount
$50,000
Year
2012
Type of award
Research grant
Recipient
Jaime Modiano, VMD, Ph.D.
Research institution
Veterinary Medicine and Masonic Cancer Center University of Minnesota
Project title
Innovative Molecular Targets for Prevention and Treatment of Canine Hemangiosarcoma.
Amount
$50,000
Help keep this research going
Your donation directly funds angiosarcoma-specific research and shared resources that benefit patients worldwide.